Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness

Elevated plasma levels of the osteocyte-derived hormone fibroblast growth factor 23 (FGF23) have emerged as a powerful biomarker of cardiovascular disease and death in patients with CKD. Whether elevated urinary or plasma FGF23 levels are prospectively associated with AKI and death in critically ill...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Leaf, David E., Jacob, Kirolos A., Srivastava, Anand, Chen, Margaret E., Christov, Marta, Jüppner, Harald, Sabbisetti, Venkata S., Martin, Aline, Wolf, Myles, Waikar, Sushrut S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2017
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461795/
https://ncbi.nlm.nih.gov/pubmed/28028134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016080836
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak